Ningbo David Medical Device Co., Ltd. (300314.SZ)
CNY 12.42
(2.14%)
CNY 12.42
(2.14%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 618.29 Million | 506.03 Million | 474.13 Million | 459.53 Million | 356.35 Million | 300.29 Million |
| Cost of Revenue | 258.47 Million | 209.73 Million | 182.2 Million | 190.07 Million | 164.74 Million | 148.05 Million |
| Gross Profit | 359.82 Million | 296.29 Million | 291.93 Million | 269.45 Million | 191.6 Million | 152.24 Million |
| Operating Expenses | 188.45 Million | 199.49 Million | 218.67 Million | 167.55 Million | 136.47 Million | 107.57 Million |
| Selling, General and Administrative Expenses | 138.78 Million | 125.16 Million | 135.15 Million | 97.97 Million | 74.68 Million | 61.75 Million |
| Research and Development Expenses | 48.05 Million | 45.86 Million | 49.69 Million | 40.22 Million | 40.32 Million | 28.25 Million |
| Other Expenses | -1.6 Million | 28.45 Million | 33.82 Million | 29.36 Million | 21.46 Million | -2.49 Million |
| Cost and Expenses | 475.07 Million | 409.23 Million | 400.87 Million | 357.63 Million | 301.22 Million | 255.62 Million |
| Operating Income | 171.36 Million | 112.01 Million | 87.22 Million | 147.8 Million | 72 Million | 42.39 Million |
| Interest Expense | 928.37 Thousand | 350.3 Thousand | 32.76 Thousand | 260.53 Thousand | 290.43 Thousand | 404.36 Thousand |
| Income Tax Expense | 18.61 Million | 14.33 Million | 6.98 Million | 10.46 Million | 7.74 Million | 11.08 Million |
| Earnings before Tax | 166.22 Million | 111.91 Million | 87.19 Million | 146.65 Million | 69.8 Million | 39.89 Million |
| Net Income | 147.61 Million | 97.35 Million | 80.2 Million | 136.19 Million | 62.05 Million | 28.81 Million |
| Earnings Per Share Basic | 0.51 | 0.34 | 0.28 | 0.47 | 0.22 | 0.10 |
| Earnings Per Share Diluted | 0.51 | 0.34 | 0.28 | 0.47 | 0.22 | 0.10 |
| Weighted Average Shares Outstanding | 289.43 Million | 288 Million | 288 Million | 288 Million | 288 Million | 288 Million |
| Weighted Average Shares Outstanding (Diluted) | 289.43 Million | 288 Million | 288 Million | 288 Million | 288 Million | 288.12 Million |
| Gross Margin | 0.58 | 0.59 | 0.62 | 0.59 | 0.54 | 0.51 |
| EBIT Margin | 0.31 | 0.27 | 0.24 | 0.37 | 0.22 | 0.28 |
| Profit Margin | 0.24 | 0.19 | 0.17 | 0.30 | 0.17 | 0.10 |
| EBITDA | 194.14 Million | 138.59 Million | 111.77 Million | 123.38 Million | 86.98 Million | 62.25 Million |
| Earnings Before Tax Margin | 0.28 | 0.22 | 0.18 | 0.32 | 0.20 | 0.14 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 137.1 Million | 108.34 Million | 154.29 Million | 159.33 Million | 618.29 Million | 141.65 Million |
| Cost of Revenue | 63.05 Million | 49.49 Million | 64.42 Million | 65.82 Million | 258.47 Million | 62.88 Million |
| Gross Profit | 74.04 Million | 58.84 Million | 89.87 Million | 93.51 Million | 359.82 Million | 78.76 Million |
| Operating Expenses | 55.92 Million | 58.52 Million | 46.9 Million | 63.17 Million | 216.6 Million | 46.49 Million |
| Selling, General and Administrative Expenses | 77.32 Million | 44.65 Million | 36.61 Million | 4.47 Million | - | 60.86 Million |
| Research and Development Expenses | 13.86 Million | 13.87 Million | 10.28 Million | 20.61 Million | - | 10.33 Million |
| Other Expenses | -35.27 Million | -43.17 Thousand | -58.74 Thousand | -4.98 Million | -5.13 Million | -23.83 Thousand |
| Cost and Expenses | 118.97 Million | 108.02 Million | 111.32 Million | 128.99 Million | 475.07 Million | 109.38 Million |
| Operating Income | 19.01 Million | 311.87 Thousand | 42.96 Million | 32.19 Million | 171.36 Million | 35.14 Million |
| Interest Expense | 111.11 Thousand | 121.41 Thousand | 132.75 Thousand | 148.41 Thousand | 598.8 Thousand | 138.06 Thousand |
| Income Tax Expense | 2.3 Million | -51.38 Thousand | 6.32 Million | 2.39 Million | 18.61 Million | 4.09 Million |
| Earnings before Tax | 19.08 Million | 10.91 Million | 47.55 Million | 27.2 Million | 166.22 Million | 35.11 Million |
| Net Income | 16.78 Million | 8.41 Million | 38.1 Million | 24.81 Million | 147.61 Million | 31.01 Million |
| Earnings Per Share Basic | 0.06 | 0.03 | 0.13 | 0.09 | - | 0.11 |
| Earnings Per Share Diluted | 0.06 | 0.03 | 0.13 | 0.09 | - | 0.11 |
| Weighted Average Shares Outstanding | 288 Million | 288 Million | 288 Million | 288 Million | 289.43 Million | 288 Million |
| Weighted Average Shares Outstanding (Diluted) | 288 Million | 288 Million | 288 Million | 288 Million | 289.43 Million | 288 Million |
| Gross Margin | 0.54 | 0.54 | 0.58 | 0.59 | 0.58 | 0.56 |
| EBIT Margin | 0.14 | 0.07 | 0.29 | 0.18 | - | 0.25 |
| Profit Margin | 0.12 | 0.08 | 0.25 | 0.16 | 0.24 | 0.22 |
| EBITDA | 19.19 Million | 7.57 Million | 45.25 Million | 29.06 Million | - | 35.77 Million |
| Earnings Before Tax Margin | 0.14 | 0.00 | 0.28 | 0.20 | 0.28 | 0.25 |
AGILC
CLCO
600587
ALPA3
ELMA
AZM